A 52-week multicenter, open-label, randomized, parallel, two - arm study comparing Exubera (inhaled human insulin) vs. Humalog (insulin lispro), both in combination with insulin glargine in subjects with type 1 diabetes mellitus.
Phase of Trial: Phase IV
Latest Information Update: 10 Aug 2017
At a glance
- Drugs Insulin; Insulin glargine; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Pfizer
- 31 Aug 2018 Biomarkers information updated
- 18 Aug 2009 Actual patient number changed from 86 to 58 as reported by ClinicalTrials.gov.
- 07 Oct 2008 Planned end date changed from 1 Jan 2009 to 1 Jun 2008 as reported by ClinicalTrials.gov.